Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the completed study record for pembrolizumab plus radiotherapy in metastatic triple-negative breast cancer, including eligibility criteria, treatment design, outcomes, study locations, and a study protocol document.
    Difference
    49%
    Check dated 2026-11-08T02:58:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error screen, with the footer revision identifier changing from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T23:09:53.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-24T23:09:09.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T23:31:58.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on an otherwise unchanged 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T23:22:45.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study record content. This blocks access to the study details, sponsor and investigator information, locations, and related data.
    Difference
    18%
    Check dated 2026-09-19T22:30:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.